TAM
TLOG

Tocqueville Asset Management’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Tocqueville Asset Management’s Portfolio TLOG Stock Details TLOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-35,500
Closed -$171K – 990
2014
Q4 		$171K Buy
+35,500
New +$159K ﹤0.01% 914

Other funds holding TLOG

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
FWC
First Washington Corp Seattle, Washington $353M AUM 41.46% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Tocqueville Asset Management's TLOG Position: Q1 2015 in Review

Tocqueville Asset Management sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q1 2015, closing a stake of 35,500 shares — an estimated $171K sold.

Tocqueville Asset Management first reported a position in TLOG in Q4 2014 and held it in 1 quarter. The position peaked at $171K in Q4 2014. 31 funds tracked by Wall St. Rank hold TLOG as of Q1 2015.

  • Tocqueville Asset Management reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q1 2015 after selling out during the quarter.
  • Tocqueville Asset Management sold 35,500 TetraLogic Pharmaceuticals Corporation shares in Q1 2015, an estimated $171K.
  • Tocqueville Asset Management first reported a position in TetraLogic Pharmaceuticals Corporation in Q4 2014 and held it in 1 quarter.
  • Tocqueville Asset Management's TetraLogic Pharmaceuticals Corporation position peaked at $171K in Q4 2014.
  • 31 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q1 2015.

Based on Tocqueville Asset Management's 13F filing for Q1 2015, filed 30 Apr 2015.